Cargando…
Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577495/ https://www.ncbi.nlm.nih.gov/pubmed/26413437 http://dx.doi.org/10.1186/s40064-015-1233-y |
| _version_ | 1782390972807643136 |
|---|---|
| author | Nattinger, Ann Butler Pezzin, Liliana E McGinley, Emily L Charlson, John A Yen, Tina W F Neuner, Joan M |
| author_facet | Nattinger, Ann Butler Pezzin, Liliana E McGinley, Emily L Charlson, John A Yen, Tina W F Neuner, Joan M |
| author_sort | Nattinger, Ann Butler |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4577495 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45774952015-09-25 Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations Nattinger, Ann Butler Pezzin, Liliana E McGinley, Emily L Charlson, John A Yen, Tina W F Neuner, Joan M Springerplus Erratum Springer International Publishing 2015-09-21 /pmc/articles/PMC4577495/ /pubmed/26413437 http://dx.doi.org/10.1186/s40064-015-1233-y Text en © Nattinger et al. 2015 Open access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Erratum Nattinger, Ann Butler Pezzin, Liliana E McGinley, Emily L Charlson, John A Yen, Tina W F Neuner, Joan M Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations |
| title | Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations |
| title_full | Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations |
| title_fullStr | Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations |
| title_full_unstemmed | Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations |
| title_short | Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations |
| title_sort | erratum to: patient costs of breast cancer endocrine therapy agents under medicare part d vs with generic formulations |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577495/ https://www.ncbi.nlm.nih.gov/pubmed/26413437 http://dx.doi.org/10.1186/s40064-015-1233-y |
| work_keys_str_mv | AT nattingerannbutler erratumtopatientcostsofbreastcancerendocrinetherapyagentsundermedicarepartdvswithgenericformulations AT pezzinlilianae erratumtopatientcostsofbreastcancerendocrinetherapyagentsundermedicarepartdvswithgenericformulations AT mcginleyemilyl erratumtopatientcostsofbreastcancerendocrinetherapyagentsundermedicarepartdvswithgenericformulations AT charlsonjohna erratumtopatientcostsofbreastcancerendocrinetherapyagentsundermedicarepartdvswithgenericformulations AT yentinawf erratumtopatientcostsofbreastcancerendocrinetherapyagentsundermedicarepartdvswithgenericformulations AT neunerjoanm erratumtopatientcostsofbreastcancerendocrinetherapyagentsundermedicarepartdvswithgenericformulations |